Cargando…
Docetaxel: an alternative taxane in ovarian cancer
The taxanes paclitaxel and docetaxel are potent chemotherapeutic agents that block tubulin depolymerisation, leading to the inhibition of microtubule dynamics and cell cycle arrest. Although docetaxel and paclitaxel share a mutual tubulin binding site, mechanistic and pharmacological differences exi...
Autor principal: | Katsumata, N |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750619/ https://www.ncbi.nlm.nih.gov/pubmed/14661041 http://dx.doi.org/10.1038/sj.bjc.6601495 |
Ejemplares similares
-
The taxanes: toxicity and quality of life considerations in advanced ovarian cancer
por: Guastalla III, J P, et al.
Publicado: (2003) -
Docetaxel: promising and novel combinations in ovarian cancer
por: Mäenpää, J U
Publicado: (2003) -
Cascade Metathesis Reactions for the Synthesis of Taxane and Isotaxane Derivatives
por: Ma, Cong, et al.
Publicado: (2016) -
Glutathione S-transferases (GSTs) polymorphism and taxane (docetaxel) sensitivity in breast cancer
por: Lee, Anbok
Publicado: (2019) -
Proteasome inhibition reverses hedgehog inhibitor and taxane resistance in ovarian cancer
por: Steg, Adam D., et al.
Publicado: (2014)